Wednesday, September 02, 2009

Hypercoagulable workup (incl effects warfarin on tests)


hat tip David Gordon, MD Professor/Chairman Neurology at OKL


Hypercoagulable Profile
􀂃 Protein C
􀂃 Protein S free and total
􀂃 Antithrombin III
􀂃 Fibrinogen
􀂃 Factor VII
􀂃 Factor VIII
􀂃 Activated protein C resistance (APCR)
􀂃 Factor V Leiden mutation
􀂃 Prothrombin G20210A mutation
􀂃 Anticardiolipin antibodies
􀂃 Anti-beta-2-glycoprotein I antibodies
􀂃 Antiphosphatidylserine antibodies
􀂃 Lupus anticoagulant
􀂃 Lipoprotein (a)
􀂃 C-reactive protein
􀂃 Methyltetrahydrofolate reductase C677T and A1298C
􀂃 Sickle prep (if African heritage)
Affect of Coumadin on Hypercoagulable Profile
􀂃 Protein C (may be decreased with warfarin)
􀂃 Protein S free and total (may be decreased with warfarin)
􀂃 Antithrombin III (not affected by warfarin)
􀂃 Fibrinogen (not affected by warfarin)
􀂃 Factor VII (may be affected by warfarin)
􀂃 Factor VIII (not affected by warfarin)
􀂃 Activated protein C resistance (must alter methods to compensate for warfarin)
􀂃 Factor V Leiden mutation (not affected by warfarin)
􀂃 Prothrombin 20210 mutation (not affected by warfarin)
􀂃 Anticardiolipin antibodies (not affected by warfarin)
􀂃 Anti-beta-2-glycoprotein I antibodies (not affected by warfarin)
􀂃 Antiphosphatidylserine antibodies (not affected by warfarin)
􀂃 Lupus anticoagulant (screening tests not affected by warfarin, but “mixing studies” to
confirm are affected by warfarin)
􀂃 Lipoprotein (a) (not affected by warfarin)
􀂃 C-reactive protein (not affected by warfarin)
􀂃 Methyltetrahydrofolate reductase C677T and A1298C (not affected by warfarin)
􀂃 Sickle prep (if African heritage) (not affected by warfarin

1 comment:

Neurodoc said...

Agree with Dr Britt's and others list. However, as many presumed arterial
infarcts are due to paradoxical embolism, I believe the division into an
arterial panel and a venous panel is somewhat artificial; such a division often
leads one into a situation where treatment has begun (perhaps prematurely, in
this age of efficiency and high /rapid turnover from in-patient to rehab or
discharge), clouding issues whether Proteins or Protein C might have been
implicated. Thus, in terms of efficiency, it may be best to obtain a thrombosis
panel.

I should like to add d-dimer, fibrinogen, plasminogen, and alpha-2-antiplasmin
to the panel. In selected cases, one must not forget the existence of other
antiphospholipid antibodies....foremost, anti-phosphatidyl-serine.


F. Buonanno, M.D.
CardioNeurology Clinic/ Stroke Service
Massachusetts General Hospital

Co-Director, Pediatric Stroke Service
Mass General Hospital for Children